SCHEMBL30879899

SCHEMBL30879899

CN(C)c1ccc(NC(=O)n2ccnc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.50
GAA P10253 5/20 0.50
KMT2A Q03164 4/20 0.50
TP53 P04637 2/20 0.50
ESR2 Q92731 2/20 0.50
MEN1 O00255 2/20 0.50
QPCT Q16769 1/20 0.47
MAPT P10636 8/20 0.47
NPC1 O15118 5/20 0.47
RAB9A P51151 5/20 0.47
ALDH1A1 P00352 4/20 0.47
TDP1 Q9NUW8 2/20 0.47
LMNA P02545 1/20 0.47
MAPK1 P28482 1/20 0.47
RECQL P46063 1/20 0.47
MCL1 Q07820 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NOX1 Q9Y5S8 2/20 0.44
NR4A1 P22736 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24001003 0.82 MDM2 (0.52) GAAKMT2AMEN1RAB9AL3MBTL1
SCHEMBL31270898 0.81 LSS (0.45) RAB9ANAMPTKDM4E
SCHEMBL10662756 0.81 GAA (0.45) GAAKMT2AMEN1MAPTALDH1A1
Imidazole-1-Carboxylic Acid Phenylamide SCHEMBL10668282 0.81 RAB9A (0.50) SMN1; SMN2GAATP53QPCTNPC1
SCHEMBL10662282 0.80 KMT2A (0.53) GAAKMT2AMEN1QPCTNPC1
SCHEMBL31402684 0.78 TSHR (0.51) KMT2ATP53MEN1MAPTNPC1
SCHEMBL21843382 0.78 HTT (0.58) SMN1; SMN2GAAKMT2AMEN1MAPT
SCHEMBL18184936 0.76 CYP19A1 (0.56) GAAKMT2AMEN1MAPTRAB9A
SCHEMBL4173548 0.75 QPCT (0.56) GAAKMT2AESR2QPCTMAPT
SCHEMBL24000883 0.74 RAB9A (0.53) SMN1; SMN2KMT2ATP53MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024092222-A1 MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR D AND RELATED PRODUCTS AND METHODS ESCIENT PHARMACEUTICALS, INC. (US) 2024-05-02 WO disclosed